SCHEMBL18314282

SCHEMBL18314282

CC1(C)c2ccccc2-c2c(-c3nc(-c4ccccc4)c4ccccc4n3)cccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
ATM Q13315 1/20 0.46
NUDT1 P36639 3/20 0.44
ADORA2A P29274 5/20 0.41
ALDH1A1 P00352 4/20 0.39
MAPT P10636 3/20 0.39
RAD52 P43351 1/20 0.39
GAA P10253 1/20 0.38
KDM4E B2RXH2 3/20 0.38
HPGD P15428 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
WHR1 P49842 1/20 0.37
L3MBTL1 Q9Y468 3/20 0.36
LMNA P02545 2/20 0.36
HTT P42858 1/20 0.36
CYP1A2 P05177 2/20 0.35
CYP2D6 P10635 2/20 0.35
CYP2C19 P33261 2/20 0.35
CLK4 Q9HAZ1 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18455506 0.95 MEN1 (0.45) MEN1KMT2AATMNUDT1ADORA2A
SCHEMBL18456129 0.93 MEN1 (0.39) MEN1KMT2AATMNUDT1ADORA2A
SCHEMBL18456126 0.92 MEN1 (0.39) MEN1KMT2AATMNUDT1ADORA2A
SCHEMBL18455508 0.92 ATM (0.41) MEN1KMT2AATMNUDT1ADORA2A
SCHEMBL18456007 0.91 MEN1 (0.43) MEN1KMT2AATMNUDT1ADORA2A
SCHEMBL22868898 0.91 MEN1 (0.43) MEN1KMT2AATMNUDT1ADORA2A
SCHEMBL18455709 0.91 MEN1 (0.52) MEN1KMT2AATMNUDT1ADORA2A
SCHEMBL21868326 0.91 MEN1 (0.43) MEN1KMT2AATMNUDT1ADORA2A
SCHEMBL18455514 0.91 MEN1 (0.46) MEN1KMT2AATMNUDT1ADORA2A
SCHEMBL18455710 0.90 ATM (0.50) MEN1KMT2AATMNUDT1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11208401-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2021-12-28 US disclosed
US-11201296-B2 Compounds having fluorene structures MERCK PATENT GMBH (DE) 2021-12-14 US disclosed
US-11201296-B2 Compounds having fluorene structures MERCK PATENT GMBH (DE) 2021-12-14 US disclosed
CN-107849016-B Compound having fluorene structure 默克专利有限公司 2021-10-22 CN disclosed
EP-3328850-B1 COMPOUNDS HAVING FLUORENE STRUCTURES MERCK PATENT GMBH (DE) 2020-11-11 EP disclosed
EP-3328850-B1 COMPOUNDS HAVING FLUORENE STRUCTURES MERCK PATENT GMBH (DE) 2020-11-11 EP disclosed
US-20180226587-A1 COMPOUNDS HAVING FLUORENE STRUCTURES MERCK PATENT GMBH (DE) 2018-08-09 US disclosed
US-20180226587-A1 COMPOUNDS HAVING FLUORENE STRUCTURES MERCK PATENT GMBH (DE) 2018-08-09 US disclosed
US-20180226587-A1 COMPOUNDS HAVING FLUORENE STRUCTURES MERCK PATENT GMBH (DE) 2018-08-09 US disclosed
US-20180162843-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2018-06-14 US disclosed
US-20180162843-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2018-06-14 US disclosed
EP-3328850-A1 COMPOUNDS HAVING FLUORENE STRUCTURES Merck Patent GmbH (DE) 2018-06-06 EP disclosed
WO-2017016667-A1 COMPOUNDS HAVING FLUORENE STRUCTURES MERCK PATENT GMBH (DE) 2017-02-02 WO disclosed
WO-2017016667-A1 COMPOUNDS HAVING FLUORENE STRUCTURES MERCK PATENT GMBH (DE) 2017-02-02 WO disclosed
WO-2016198144-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2016-12-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180226587-A1 COMPOUNDS HAVING FLUORENE STRUCTURES FSCN1, EFNA1, FLNA MEN1 1658/4885KMT2A 2095/4885ATM 4239/4885
US-11208401-B2 Materials for organic electroluminescent devices DDT, CELF2, BRD3 MEN1 3573/4885KMT2A 2313/4885ATM 4330/4885
US-11201296-B2 Compounds having fluorene structures FSCN1, EFNA1, FLNA MEN1 1658/4885KMT2A 2095/4885ATM 4239/4885
US-20180162843-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES DDT, CELF2, BRD3 MEN1 3573/4885KMT2A 2313/4885ATM 4330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.